Stock market today: The Indian stock market remained under bearish pressure as the benchmark Sensex plunged another 800 ...

Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!

Biocon Limited ( (IN:BIOCON)) just unveiled an update. Biocon Limited has increased its ownership in its unlisted material subsidiary, Biocon Biologics Limited (BBL), to around 94% of BBL’s fully ...

The market is expected to see consolidation with range-bound trading in the next few sessions. Below are some short-term trading ideas to consider.

Stocks of Indian Renewable Energy Development Agency Ltd., Max Financial Services Ltd., Tata Steel Ltd., Biocon Ltd. and ...

CESC said it has incorporated four new wholly owned subsidiaries Purvah Navurja, Purvah Cleantech, Purvah Bikaner-V One Power and Purvah Clean Energy. Adani Energy Solutions said its arm Adani ...

Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S's Ozempic and Wegovy in key markets as patents on the blockbuster weight-loss drugs expire next year. The ...

Stocks in news often attract significant attention from traders and investors as corporate developments, sector trends, and ...

LA JOLLA, Calif.--(BUSINESS WIRE)-- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, ...

Biocon Limited on Tuesday received USFDA approval for its generic version of Liraglutide Injection (18 mg/3 mL), a GLP-1 weight management drug sold under the brand name Saxenda, marking the company’s ...